NAUT
Nautilus Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.33
−1.06%Margins
Gross margin
-362.5%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-50.3%
Return on equity
-39.3%
Return on assets
-44.7%
Return on invested capital
0.00x
Asset turnover
-$52.5M
Cash from operations
$0.68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026